Literature DB >> 27296879

General practitioners' decisions about discontinuation of medication: an explorative study.

Michael Simon Nixon1, Morten Thanning Vendelø2.   

Abstract

Purpose - The purpose of this paper is to investigate how general practitioners' (GPs) decisions about discontinuation of medication are influenced by their institutional context. Design/methodology/approach - In total, 24 GPs were interviewed, three practices were observed and documents were collected. The Gioia methodology was used to analyse data, drawing on a theoretical framework that integrate the sensemaking perspective and institutional theory. Findings - Most GPs, who actively consider discontinuation, are reluctant to discontinue medication, because the safest course of action for GPs is to continue prescriptions, rather than discontinue them. The authors conclude that this is in part due to the ambiguity about the appropriateness of discontinuing medication, experienced by the GPs, and in part because the clinical guidelines do not encourage discontinuation of medication, as they offer GPs a weak frame for discontinuation. Three reasons for this are identified: the guidelines provide dominating triggers for prescribing, they provide weak priming for discontinuation as an option, and they underscore a cognitive constraint against discontinuation. Originality/value - The analysis offers new insights about decision making when discontinuing medication. It also offers one of the first examinations of how the institutional context embedding GPs influences their decisions about discontinuation. For policymakers interested in the discontinuation of medication, the findings suggest that de-stigmatising discontinuation on an institutional level may be beneficial, allowing GPs to better justify discontinuation in light of the ambiguity they experience.

Keywords:  Decision making; Deprescribing; Discontinuation; General practitioners; Institutional context; Medication

Mesh:

Substances:

Year:  2016        PMID: 27296879     DOI: 10.1108/JHOM-01-2015-0011

Source DB:  PubMed          Journal:  J Health Organ Manag        ISSN: 1477-7266


  5 in total

Review 1.  Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.

Authors:  Joanne Reeve; Michelle Maden; Ruaraidh Hill; Amadea Turk; Kamal Mahtani; Geoff Wong; Dan Lasserson; Janet Krska; Dee Mangin; Richard Byng; Emma Wallace; Ed Ranson
Journal:  Health Technol Assess       Date:  2022-07       Impact factor: 4.106

2.  Evaluating the impact of a polypharmacy Action Learning Sets tool on healthcare practitioners' confidence, perceptions and experiences of stopping inappropriate medicines.

Authors:  Cindy Faith Brooks; Anastasios Argyropoulos; Catherine Brigitte Matheson-Monnet; David Kryl
Journal:  BMC Med Educ       Date:  2022-06-27       Impact factor: 3.263

3.  The STOP-AB trial protocol: efficacy and safety of discontinuing patient antibiotic treatment when physicians no longer consider it necessary.

Authors:  Carl Llor; Ana Moragas; Carolina Bayona; Josep M Cots; José M Molero; Joana Ribas; Julio Francisco Fóthy; Isabel Gutiérrez; Coro Sánchez; Jesús Ortega; Javier Arranz; Jenifer Botanes; Purificación Robles
Journal:  BMJ Open       Date:  2017-06-06       Impact factor: 2.692

4.  Towards Inclusive Healthcare Delivery: Potentials and Challenges of Human-Centred Design in Health Innovation Processes to Increase Healthy Aging.

Authors:  Catharina Thiel Sandholdt; Jason Cunningham; Rudi G J Westendorp; Maria Kristiansen
Journal:  Int J Environ Res Public Health       Date:  2020-06-24       Impact factor: 3.390

Review 5.  Making patient values visible in healthcare: a systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity.

Authors:  Dee Mangin; Gaibrie Stephen; Verdah Bismah; Cathy Risdon
Journal:  BMJ Open       Date:  2016-06-10       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.